ADRIAN ADAMS
CIK 1248144 · COB, CEO and President · last filed 2025-10-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$200.7K
Companies
10
Total Filings
61
Lifetime Open-Market Net
$8.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLPH | Director | 17,609 | $0.87 | $15.4K | $0 | 2 | 2025-10-24 |
| AKBA | Director | 200,500 | $0.92 | $185.4K | $170.5K | 9 | 2025-06-11 |
| TALPHERA, INC. (ACRX) Delisted | Director | 11,168 | $0.86 | $9.6K | $614.0K | 15 | 2023-12-13 |
| IPI Legacy Liquidation Co (IMPL) Delisted | COB, CEO and President | 17,203 | $0.24 | $4.1K | $279.8K | 4 | 2023-02-16 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Chief Executive Officer | 3,787,610 | — | — | $1.23M | 4 | 2017-05-12 |
| POZEN INC /NC (POZN) Delisted | Chief Executive Officer | 2,496,359 | — | — | $6.55M | 2 | 2015-11-12 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | CEO and President | 120,134 | — | — | -$1.36M | 7 | 2015-01-30 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 21,000 | — | — | $0 | 6 | 2012-05-17 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | President and CEO | 0 | — | — | $0 | 4 | 2011-05-16 |
| SEPRACOR INC /DE/ (SEPR) Delisted | President & CEO | 241,667 | — | — | $1.05M | 5 | 2009-10-19 |
Recent Filings · Page 4 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-24 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-05 | POZEN INC /NC (POZN) Delisted | Grant (A) | +1,944,888 | $0 | EDGAR |
| 2015-01-30 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Other (J) | −217,778 | -$4.39M | EDGAR |
| 2014-12-08 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Mixed | — | -$662.7K | EDGAR |
| 2014-07-28 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-12 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | +114,100 | $0 | EDGAR |
| 2014-02-20 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | +86,275 | $0 | EDGAR |
| 2013-09-16 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | — | $0 | EDGAR |
| 2013-05-29 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | +75,000 | $614.0K | EDGAR |
| 2013-02-13 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.